1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Unresectable Gastroesophageal Junction Carcinoma: new trials by email Literature Review of Unresectable Gastroesophageal Junction Carcinoma trials Research Report on Unresectable Gastroesophageal Junction Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Phase 1 | Not yet recruiting | Northwestern University | 18 | 2027-09-09 | 2026-10-20 |
Adenocarcinoma Of Esophagus (1)
Magnetic Resonance Spectroscopy (1) · Paclitaxel (1) · Ramucirumab (1) · Specimen Handling (1) · Taxes (1) · futibatinib (1)
United States (1)
P30CA060553 (1)